0,869  0,009  Apoptosis agonist
0,857  0,004  Nitric oxide antagonist
0,859  0,008  Antiinflammatory
0,828  0,004  Sensitization
0,776  0,011  Antineoplastic (breast cancer)
0,754  0,005  Bone diseases treatment
0,749  0,005  Antiosteoporotic
0,753  0,009  Antileukemic
0,724  0,007  Antiprotozoal
0,695  0,005  Antiprotozoal (Plasmodium)
0,670  0,006  Antipsoriatic
0,664  0,003  Contraceptive
0,666  0,008  Antineoplastic (melanoma)
0,661  0,006  Antineoplastic (pancreatic cancer)
0,637  0,003  Antiacne
0,624  0,003  Postmenopausal disorders treatment
0,611  0,012  Immunosuppressant
0,613  0,014  Antineoplastic (ovarian cancer)
0,591  0,003  Contraceptive male
0,557  0,005  Prostatic (benign) hyperplasia treatment
0,581  0,033  Antineoplastic (lung cancer)
0,552  0,007  Antineoplastic (carcinoma)
0,550  0,012  Antiprotozoal (Leishmania)
0,544  0,017  Immunomodulator
0,559  0,036  Transcription factor NF kappa B inhibitor
0,522  0,004  Prostate disorders treatment
0,521  0,004  Antialcoholic
0,513  0,007  Hair growth stimulant
0,520  0,018  Antifungal
0,504  0,009  Antineoplastic (liver cancer)
0,524  0,032  Antineoplastic (colorectal cancer)
0,511  0,018  Cardiovascular analeptic
0,497  0,007  Antineoplastic (squamous cell carcinoma)
0,520  0,031  Antineoplastic (colon cancer)
0,513  0,037  Antibacterial
0,496  0,023  Hepatic disorders treatment
0,501  0,032  Prostate cancer treatment
0,469  0,009  Hepatoprotectant
0,470  0,018  ICAM1 expression inhibitor
0,437  0,005  Sepsis treatment
0,431  0,004  Contraceptive female
0,464  0,044  Antipruritic, allergic
0,418  0,007  Protein kinase stimulant
0,457  0,049  CYP3A4 substrate
0,437  0,030  Antineoplastic (brain cancer)
0,422  0,018  Antineoplastic enhancer
0,416  0,014  Abortion inducer
0,470  0,073  Caspase 9 stimulant
0,419  0,033  Apoptosis antagonist
0,388  0,008  Antiviral (Influenza A)
0,381  0,006  Antifungal enhancer
0,385  0,012  Antiviral (Influenza)
0,408  0,038  AR expression inhibitor
0,389  0,021  Antiulcerative
0,374  0,011  Pneumotoxic
0,389  0,029  Chemopreventive
0,390  0,033  Antineoplastic (multiple myeloma)
0,358  0,004  Antifungal (Cryptococcus)
0,365  0,014  Antipruritic, non-allergic
0,384  0,035  NOS2 expression inhibitor
0,393  0,046  Respiratory analeptic
0,373  0,027  Angiogenesis stimulant
0,377  0,034  Calcium channel activator
0,341  0,015  Interferon gamma antagonist
0,354  0,036  Antineoplastic (lymphoma)
0,359  0,044  Antineoplastic (glioma)
0,314  0,002  SULT1E1 substrate
0,391  0,081  TNF expression inhibitor
0,322  0,022  UGT2B7 substrate
0,338  0,041  Tumour necrosis factor alpha release inhibitor
0,295  0,003  Hypercalcemia treatment
0,325  0,041  Antineoplastic (glioblastoma multiforme)
0,285  0,005  Aromatase inhibitor
0,298  0,023  Antieczematic atopic
0,304  0,030  UGT1A4 substrate
0,300  0,030  Antihypotensive
0,329  0,059  Analeptic
0,278  0,008  Farnesoid X receptor antagonist
0,256  0,005  Actinic keratosis treatment
0,253  0,005  Inducible nitric-oxide synthase inhibitor
0,246  0,004  5-Alpha-reductase inhibitor
0,267  0,028  Diuretic
0,299  0,062  Antioxidant
0,245  0,010  Microtubule formation inhibitor
0,273  0,042  UDP-glucuronosyltransferase substrate
0,267  0,038  VCAM1 expression inhibitor
0,265  0,048  Antiparkinsonian, rigidity relieving
0,221  0,009  Antineoplastic alkaloid
0,300  0,088  FMO1 substrate
0,230  0,021  Protein-tyrosine phosphatase 1B inhibitor
0,281  0,075  Radioprotector
0,269  0,068  Antineoplastic (renal cancer)
0,308  0,110  Antineoplastic (myeloid leukemia)
0,272  0,075  UGT2B4 substrate
0,254  0,061  Cytotoxic
0,196  0,004  Anabolic
0,260  0,071  5 Hydroxytryptamine uptake stimulant
0,217  0,031  UGT2B9 substrate
0,256  0,072  Proliferative diseases treatment
0,195  0,012  Pregnane X receptor agonist
0,249  0,067  DNA synthesis inhibitor
0,186  0,006  Antiprotozoal activity enhancer
0,201  0,020  Endometrios treatment
0,185  0,009  Estrogen agonist
0,203  0,027  Antiviral (Hepatitis B)
0,206  0,033  UGT2B10 substrate
0,190  0,021  Antischistosomal
0,257  0,088  CYP2C19 substrate
0,217  0,048  Antiviral (Hepatitis)
0,200  0,033  Arachidonic acid antagonist
0,272  0,109  Antithrombotic
0,205  0,045  Protein-tyrosine phosphatase inhibitor
0,185  0,026  Antismoking
0,273  0,114  Antineoplastic (endocrine cancer)
0,216  0,056  CYP2B6 inhibitor
0,175  0,017  Androgen antagonist
0,187  0,029  Antitussive
0,164  0,009  T cell inhibitor
0,216  0,062  Neurotrophic factor enhancer
0,157  0,003  Postcoital contraceptive
0,152  0,003  Vitamin D receptor antagonist
0,156  0,007  Cannabinoid CB2 receptor antagonist
0,210  0,066  Platelet adhesion inhibitor
0,168  0,027  Antineoplastic antibiotic
0,207  0,068  UGT1A1 substrate
0,216  0,078  RNA-directed DNA polymerase inhibitor
0,163  0,030  Menstruation disorders treatment
0,154  0,021  Nitric-oxide synthase inhibitor
0,266  0,135  CYP2C9 substrate
0,153  0,022  Antispirochetal
0,239  0,112  NOS3 expression inhibitor
0,214  0,088  Teratogen
0,206  0,082  Antiparasitic
0,194  0,070  Antihelmintic
0,154  0,032  Shock treatment
0,130  0,009  Androgen agonist
0,129  0,009  Narcotic antagonist
0,129  0,012  Na+ K+ transporting ATPase inhibitor
0,228  0,113  Antiepileptic
0,135  0,023  UGT2B11 substrate
0,160  0,048  Adenylate cyclase stimulant
0,187  0,076  Carcinogenic
0,165  0,054  Anesthetic
0,241  0,132  Cholesterol antagonist
0,155  0,049  Antieczematic
0,179  0,072  Lipocortins synthesis antagonist
0,108  0,003  Parathyroid hormone antagonist
0,173  0,072  Sigma receptor agonist
0,133  0,034  Estrogen antagonist
0,106  0,008  Glutamate (mGluR6) antagonist
0,229  0,132  GST M1-1 substrate
0,174  0,077  Antirickettsial
0,143  0,046  Vanilloid 1 agonist
0,105  0,009  Progesterone antagonist
0,103  0,008  Mineralocorticoid receptor antagonist
0,123  0,028  Paget's disease treatment
0,101  0,006  Sphingosine 1-phosphate receptor 3 agonist
0,097  0,004  Progesterone agonist
0,128  0,035  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,135  0,043  TRPA1 agonist
0,195  0,104  Cytostatic
0,156  0,065  UGT2B15 substrate
0,210  0,121  Transcription factor STAT3 inhibitor
0,097  0,010  SULT2A1 substrate
0,185  0,098  Embryotoxic
0,113  0,027  Bile acid receptor antagonist
0,203  0,118  Interleukin agonist
0,094  0,009  Aldosterone antagonist
0,113  0,029  Transcription factor NF kappa B stimulant
0,189  0,109  Antineoplastic (cervical cancer)
0,193  0,114  Antipyretic
0,125  0,049  Choleretic
0,094  0,024  Hyperparathyroidism treatment
0,193  0,125  Spasmolytic
0,143  0,076  Acaricide
0,078  0,011  Anesthetic inhalation
0,069  0,002  Progesterone receptor B antagonist
0,165  0,099  Non-steroidal antiinflammatory agent
0,163  0,098  P-glycoprotein inhibitor
0,099  0,035  Antibiotic
0,069  0,006  Hypogonadism treatment
0,148  0,085  Melanin inhibitor
0,154  0,095  ATPase inhibitor
0,196  0,138  Chemoprotective
0,113  0,055  Antiprotozoal (Toxoplasma)
0,069  0,017  Sphingosine 1-phosphate receptor 5 agonist
0,063  0,012  Microtubule stabilization
0,142  0,091  Mutagenic
0,185  0,135  5 Hydroxytryptamine release stimulant
0,052  0,005  CYP24 inhibitor
0,053  0,007  5-Alpha-reductase 2 inhibitor
0,083  0,038  Cannabinoid receptor antagonist
0,124  0,080  Skin whitener
0,051  0,008  Tubulin agonist
0,105  0,062  Antihypermotility
0,152  0,109  LDLR expression enhancer
0,073  0,031  Andropause treatment
0,047  0,005  Glutamate (mGluR3) agonist
0,135  0,094  Ca2+-transporting ATPase inhibitor
0,066  0,026  Lipocortins synthesis agonist
0,047  0,007  5-Alpha-reductase 1 inhibitor
0,140  0,100  Uterine stimulant
0,079  0,040  Glycine receptor agonist
0,082  0,045  Estrogen receptor alpha antagonist
0,279  0,242  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,062  0,027  Pregnane X receptor antagonist
0,081  0,047  Keratolytic
0,110  0,076  Cholesterol synthesis inhibitor
0,044  0,010  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,174  0,140  DNA damaging
0,048  0,016  Glucocorticoid antagonist
0,209  0,176  Sodium/bile acid cotransporter inhibitor
0,152  0,120  Antimitotic
0,099  0,068  GABA C receptor agonist
0,037  0,006  Nicotinic acid receptor 2 antagonist
0,059  0,028  Nicotinic alpha3beta2 receptor antagonist
0,045  0,015  Glutamate (mGluR8) agonist
0,082  0,053  Glycine receptor antagonist
0,062  0,033  Cannabinoid CB2 receptor agonist
0,072  0,043  Anticholelithogenic
0,042  0,019  Nicotinic acid receptor 2 agonist
0,056  0,034  Protein 50S ribosomal subunit inhibitor
0,094  0,071  Sulfotransferase substrate
0,066  0,044  Cannabinoid receptor agonist
0,031  0,010  Toll-Like receptor 4 agonist
0,126  0,105  Eye irritation, high
0,075  0,054  Antitreponemal
0,024  0,005  NMDA receptor phencyclidine site antagonist
0,031  0,012  Retinoid X gamma receptor antagonist
0,029  0,011  Vanilloid 2 agonist
0,043  0,025  Kainate receptor agonist
0,025  0,008  Retinoid X beta receptor antagonist
0,028  0,012  Retinoid X gamma receptor agonist
0,038  0,022  Estrogen receptor alpha agonist
0,041  0,025  Membrane dipeptidase inhibitor
0,037  0,022  Retinoid X alpha receptor agonist
0,060  0,046  Heme oxygenase stimulant
0,072  0,059  Vanilloid 4 agonist
0,072  0,059  Nicotinic alpha4beta2 receptor antagonist
0,092  0,079  Gout treatment
0,097  0,084  GST T1-1 substrate
0,037  0,024  Retinoid X receptor agonist
0,014  0,004  Progesterone receptor A antagonist
0,034  0,025  Retinoid X alpha receptor antagonist
0,037  0,028  Retinoid X receptor antagonist
0,124  0,115  Raynaud's phenomenon treatment
0,036  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,017  0,010  Vitamin D receptor agonist
0,022  0,016  Retinoic acid gamma receptor agonist
0,058  0,051  Antimycoplasmal
0,020  0,015  Retinoid X beta receptor agonist
0,007  0,002  Vitamin D-like
0,030  0,026  ATP citrate lysase inhibitor
0,026  0,023  RNA-directed RNA polymerase stimulant
0,079  0,077  Antidote, mercury
0,129  0,127  Carcinogenic, group 1
0,055  0,055  Ryanodine receptor antagonist

